Recent developments in Japanese financial markets suggest that traditional relationships between foreign exchange and interest rate markets may be evolving. Analysis of OTC derivatives data, alongside movements in USD/JPY, Japanese rates and equities, highlights a potential shift in the factors driving market pricing.
A Shift Beyond Interest Rate Differentials
For much of the period between 2020 and mid-2025, USD/JPY moved largely in line with the Japan-U.S. interest rate differential. As U.S. rates rose and the differential widened, the yen weakened accordingly.
Market interventions and Bank of Japan policy adjustments periodically influenced the exchange rate, but the broader relationship remained intact. OTC rate markets, spot FX markets and policy expectations generally pointed in the same direction.
However, from late 2025 onwards, a divergence began to emerge.
Despite a narrowing Japan-U.S. interest rate differential driven by U.S. rate cuts, USD/JPY continued to move higher. This suggests that market participants may have started to focus on factors beyond rate differentials alone when assessing the outlook for the yen.
What Interest Rate Markets Are Pricing
Interest rate markets provide valuable insight into changing expectations for Japanese monetary policy.
Forward TONA swap curves have moved significantly higher since October 2025, indicating that markets have steadily increased expectations for future policy tightening.
Notably, a previously identifiable peak in the curve around the estimated neutral rate range of 1.7% to 2.0% has gradually disappeared. Rather than pricing a clear end point for the tightening cycle, markets appear to be assigning greater probability to rates remaining higher for longer or potentially moving above previously expected levels.
This highlights an important change in market pricing. While expectations for higher rates have increased, those expectations have not resulted in sustained yen appreciation.
An Unusual Market Combination
Since October 2025, Japanese markets have exhibited a combination of:
- Yen depreciation
- Rising Japanese equity prices
- Rising interest rates
Between October 2025 and June 2026:
- USD/JPY rose from 147.47 to 160.30
- The Nikkei 225 increased from 45,770 to 66,600
- TONA forward curves shifted materially higher across maturities
Historically, these variables have not always moved in the same direction. Rising interest rates are often associated with tighter financial conditions, which can weigh on equity valuations.
The current market structure therefore presents an interesting case study in how inflation expectations, fiscal policy expectations and monetary policy pricing can interact across asset classes.
Reading Policy Expectations Through OTC Markets
The divergence between FX and rates markets highlights the importance of analysing OTC pricing alongside headline policy developments.
Market participants have increasingly focused on:
- Expectations for future Bank of Japan policy
- Fiscal policy developments
- Japanese government bond supply dynamics
- Balance sheet considerations related to the Bank of Japan’s substantial holdings of government bonds and ETFs
As a result, OTC markets may be providing a broader signal than policy rates alone. Changes in swap curves, forward pricing and rate expectations offer insight into how investors view the medium-term economic and policy environment.
The Importance of Yield Curve Analysis
One of the clearest signals has emerged through the evolution of the TONA forward curve.
The repricing across the curve suggests that markets are reassessing not only the pace of future tightening but the level at which Japanese rates may ultimately stabilise.
At the same time, comparisons between TONA and SOFR forward curves indicate that even if Japanese policy rates move towards 2%, a meaningful Japan-U.S. rate differential could still remain in place.
This reinforces the idea that exchange rate dynamics cannot be explained solely through interest rate differentials and underlines the value of monitoring multiple OTC market indicators together.
Key Market Considerations
The data points to a market environment in which participants are simultaneously pricing:
- Higher Japanese interest rates
- Persistent inflation pressures
- A weaker yen
- Stronger equity performance
Whether this combination proves sustainable remains an important question for investors.
For market participants, the evolution of USD/JPY, TONA swap curves and broader OTC interest rate pricing will continue to provide valuable insight into how expectations around monetary policy, inflation and fiscal developments are being incorporated into market valuations.
As the relationship between FX and rates continues to evolve, OTC market data remains a critical tool for understanding the signals being sent across asset classes and identifying shifts in market structure before they become visible in traditional economic indicators.
About Parameta Solutions
Understanding the evolving relationship between foreign exchange and interest rate markets requires access to reliable OTC market data and transparent pricing. Parameta Solutions provides independent pricing, reference data and analytics across global FX and rates markets, helping market participants monitor policy expectations, yield curve dynamics and cross-asset market signals. From FX forwards and swaps to interest rate swaps and benchmark curves, our data helps firms gain deeper insight into market sentiment and make more informed trading, investment and risk management decisions.
To access more information about our interest rates swaps, interest rate options or FX data solutions, please contact us for a data sample or further information.
Disclaimer
© 2026 ICAP Information Services Limited (“IISL”). This communication is provided by ICAP Information Services Limited or a member of its group (“Parameta”) and all information contained in or attached hereto (the “Information”) is for information purposes only and is confidential. Access to the Information by anyone other than the intended recipient is unauthorised without Parameta’s prior written approval. The Information may not be not used or disclosed for any purpose without Parameta’s prior written approval, including without limitation, storing, copying, distributing, licensing, selling or displaying the Information, using the Information in an application or to create derived data of any kind, co-mingling the Information with any other data or using the data for any unlawful purpose of for any purpose that would cause it to become a benchmark under any law, regulation or guidance. The Information is not, and should not be construed as, a live price, an offer, bid, recommendation or solicitation in relation to any financial instrument or investment or to participate in any particular trading strategy or constituting financial or investment advice or a financial promotion. The Information does not constitute a public offer under any applicable legislation or an offer to sell or a solicitation of an offer to buy any securities. The Information is not to be relied upon for any purpose whatsoever and is provided “as is” without warranty of any kind, either expressly or by implication, including without limitation as to completeness, timeliness, accuracy, continuity, merchantability or fitness for any particular purpose. All representations and warranties are expressly disclaimed, to the fullest extent possible under applicable law. In no circumstances will Parameta be liable for any indirect or direct loss, or consequential loss or damages including without limitation, loss of business or profits arising from the use of or any inability to use the Information, or any inaccuracy in the Information. Parameta may suspend, withdraw or modify or change the terms of the provision of the Information at any time in its sole discretion, without notice. All rights, including without limitation intellectual property rights, in and to the Information are, and shall remain, the property of IISL or its licensors. Use of, access to or delivery of Parameta’s products and/or services requires a prior written licence from Parameta or its relevant affiliates. The terms of this disclaimer are governed by the laws of England and Wales.